High uptake of HPV immunisation in Scotland - perspectives on maximising uptake

被引:6
|
作者
Potts, A. [1 ]
Sinka, K. [1 ]
Love, J. [1 ]
Gordon, R. [2 ]
McLean, S. [1 ]
Malcolm, W. [1 ]
Ross, D. [1 ]
Donaghy, M. [1 ]
机构
[1] NHS Natl Serv Scotland, Hlth Protect Scotland, Glasgow, Lanark, Scotland
[2] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland
来源
EUROSURVEILLANCE | 2013年 / 18卷 / 39期
关键词
D O I
10.2807/1560-7917.ES2013.18.39.20593
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
In September 2008, Scotland introduced a national human papillomavirus (HPV) immunisation programme with bivalent HPV vaccine, to prevent cervical cancer. This school-based programme routinely vaccinates girls aged between 12 and 13 years. A catch-up campaign, running over three years, also began at this time, offering vaccination to all girls aged 13 years to under 18 years old. The HPV immunisation campaign presented challenges due to this vaccine being targeted to girls in school and older girls who had left school. Following a long and comprehensive planning process, this campaign was successfully implemented across Scotland, delivering high vaccine uptake of 91.4% for three doses of vaccine in the first year (September 2008 to August 2009) for the routine cohort and 90.1% in the second year (September 2009 to August 2010) for the routine cohort. We describe the planning process, challenges and implementation strategies employed to achieve this high uptake.
引用
收藏
页码:16 / 25
页数:10
相关论文
共 50 条
  • [21] Factors influencing the uptake of childhood immunisation in rural areas
    Henderson, R
    Oates, K
    Macdonald, H
    Smith, WCS
    Selvaraj, S
    BRITISH JOURNAL OF GENERAL PRACTICE, 2004, 54 (499): : 114 - 118
  • [22] Health Care Providers' Perspectives on Low HPV Vaccine Uptake and Adherence in Appalachian Kentucky
    Head, Katharine J.
    Vanderpool, Robin C.
    Mills, Laurel A.
    PUBLIC HEALTH NURSING, 2013, 30 (04) : 351 - 360
  • [23] Improving vaccination uptake with the implementation of an immunisation Nurse Practitioner
    Elia, Sonja
    Perrett, Kirsten
    Newell, Fiona
    AUSTRALIAN JOURNAL OF ADVANCED NURSING, 2021, 38 (02) : 65 - 68
  • [24] Challenges related to human papillomavirus (HPV) vaccine uptake in Minnesota: clinician and stakeholder perspectives
    Yared, Nicholas
    Malone, Molly
    Welo, Estee
    Mohammed, Inari
    Groene, Emily
    Flory, Matthew
    Basta, Nicole E.
    Horvath, Keith J.
    Kulasingam, Shalini
    CANCER CAUSES & CONTROL, 2021, 32 (10) : 1107 - 1116
  • [25] Does primary immunisation status predict MMR uptake?
    Pearce, A.
    Elliman, D.
    Law, C.
    Bedford, H.
    ARCHIVES OF DISEASE IN CHILDHOOD, 2009, 94 (01) : 49 - 51
  • [26] Spatial access inequities and childhood immunisation uptake in Kenya
    Noel K. Joseph
    Peter M. Macharia
    Paul O. Ouma
    Jeremiah Mumo
    Rose Jalang’o
    Peter W. Wagacha
    Victor O. Achieng
    Eunice Ndung’u
    Peter Okoth
    Maria Muñiz
    Yaniss Guigoz
    Rocco Panciera
    Nicolas Ray
    Emelda A. Okiro
    BMC Public Health, 20
  • [27] Maximising and evaluating the uptake, use and impact of golf and health studies
    Murray, Andrew
    Kelly, Paul
    Morton, Sarah
    Glover, Danny
    Duncan, Jennifer
    Hawkes, Roger
    Grant, Liz
    Mutrie, Nanette
    BRITISH JOURNAL OF SPORTS MEDICINE, 2020, 54 (20) : 1217 - 1224
  • [28] Maximising the uptake of evidence into clinical practice: an information economics approach
    Coiera, E
    MEDICAL JOURNAL OF AUSTRALIA, 2001, 174 (09) : 467 - 470
  • [29] Impact of HPV Vaccine Availability on Uptake
    Small, Stephanie L.
    Patel, Divya A.
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2012, 8 (01): : 61 - 66
  • [30] INFLUENZA IMMUNISATION OF DOCTORS AT AN AUSTRALIAN TERTIARY HOSPITAL: IMMUNISATION RATE AND FACTORS CONTRIBUTING TO UPTAKE
    Kaufman, Jonathan
    Davis, Joshua
    Krause, Vicki
    COMMUNICABLE DISEASES INTELLIGENCE, 2008, 32 (04) : 443 - 448